An increasing number of healthcare centers are expected to accelerate the global market growth for hemophilia. This would be a 5.3% compound annual growth rate. The past valuation of the global market was 12.1 billion in 2021.
According to Vantage Market Research, "The limited treatment therapy alternatives available and the growing regulatory burden on regulatory authorities to address it result in increased R&D initiatives. Furthermore, increased public awareness campaigns and supportive actions, such as the government's proposal to begin early neonatal screening, are projected to increase the demand for Hemophilia diagnostic equipment."
Read the full review here: https://www.vantagemarketresearch.com/industry-report/hemophilia-market-1216
Want to learn more about bleeding disorders? Sign up for our newsletter here! SIGN UP
Comments